Regeneron Pharmaceuticals, Inc. (REGN)
805.02
-14.07
(-1.72%)
USD |
NASDAQ |
Oct 23, 16:00
805.07
+0.05
(+0.01%)
After-Hours: 20:00
Regeneron Pharmaceuticals Price : 805.02 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 819.09 | 819.09 | 801.22 | 805.02 | 527739.0 |
| Oct 22, 2026 | 809.01 | 825.52 | 800.00 | 819.09 | 852594.0 |
| Oct 21, 2026 | 806.74 | 813.86 | 800.24 | 805.67 | 581051.0 |
| Oct 20, 2026 | 793.85 | 807.86 | 789.69 | 807.48 | 623400.0 |
| Oct 19, 2026 | 792.59 | 800.00 | 780.83 | 782.04 | 489580.0 |
| Oct 16, 2026 | 803.01 | 805.68 | 787.32 | 790.74 | 653725.0 |
| Oct 15, 2026 | 802.33 | 809.49 | 792.58 | 796.34 | 798909.0 |
| Oct 14, 2026 | 758.16 | 781.84 | 755.21 | 778.36 | 879091.0 |
| Oct 13, 2026 | 762.48 | 765.60 | 743.57 | 753.12 | 629557.0 |
| Oct 12, 2026 | 748.67 | 768.66 | 744.96 | 762.81 | 618294.0 |
| Oct 09, 2026 | 737.20 | 751.27 | 732.83 | 746.54 | 466026.0 |
| Oct 08, 2026 | 742.12 | 744.50 | 723.65 | 739.57 | 500296.0 |
| Oct 07, 2026 | 738.05 | 753.68 | 734.18 | 742.12 | 626433.0 |
| Oct 06, 2026 | 734.61 | 740.51 | 727.16 | 738.72 | 615062.0 |
| Oct 05, 2026 | 734.36 | 736.42 | 722.02 | 726.47 | 695028.0 |
| Oct 02, 2026 | 740.50 | 742.50 | 729.20 | 735.20 | 613950.0 |
| Oct 01, 2026 | 766.53 | 777.43 | 726.02 | 734.81 | 1.043M |
| Sep 30, 2026 | 749.84 | 763.72 | 742.94 | 758.27 | 872457.0 |
| Sep 29, 2026 | 745.85 | 752.47 | 741.83 | 750.51 | 804336.0 |
| Sep 28, 2026 | 778.09 | 780.94 | 750.00 | 752.25 | 1.150M |
| Sep 25, 2026 | 803.87 | 803.87 | 784.13 | 788.04 | 592146.0 |
| Sep 24, 2026 | 801.59 | 807.20 | 789.39 | 796.02 | 602654.0 |
| Sep 23, 2026 | 805.23 | 813.53 | 790.02 | 801.82 | 721110.0 |
| Sep 22, 2026 | 802.48 | 811.66 | 791.31 | 803.90 | 600266.0 |
| Sep 21, 2026 | 786.03 | 801.44 | 779.96 | 798.17 | 704527.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 439.26 |
| AbbVie, Inc. | 285.64 |
| Biogen, Inc. | 250.69 |
| Incyte Corp. | 115.71 |
| Vertex Pharmaceuticals, Inc. | 523.93 |
Price Related Metrics
| PE Ratio | 19.90 |
| PS Ratio | 5.55 |
| PEG Ratio | 10.18 |
| Price to Book Value | 2.625 |
| Price to Free Cash Flow | 24.12 |
| Earnings Yield | 5.03% |
| Market Cap | 83.24B |
| PEGY Ratio | 8.244 |
| Operating PE Ratio | 20.66 |
| Normalized PE Ratio | 18.77 |